Schrodinger Business Summary

Schrödinger, Inc. (SDGR) operates a dual-segment business model centered on its proprietary physics-based and AI-driven computational platform for molecular discovery. The Software segment generates high-margin recurring revenue through multi-year subscriptions and licensing of its platform, including the LiveDesign informatics suite, to nearly all of the world’s top 20 pharmaceutical companies and various materials science firms. The Drug Discovery segment captures long-term value through a hybrid approach of internal pipeline development and strategic collaborations, earning revenue via upfront payments, research funding, and substantial clinical/commercial milestones and royalties. Direct competitors include Dassault Systèmes (BIOVIA), Certara, and Cadence Design Systems (OpenEye), as well as AI-native biotechs like Recursion Pharmaceuticals. Schrödinger distinguishes itself as the industry’s foundational "design engine," providing the underlying physics-based simulations that enable these rivals and partners to overcome data scarcity in the drug development process. Founded in 1990 by Dr. Richard Friesner of Columbia University and Dr. William Goddard III of Caltech, the company is led by a veteran executive team with deep roots in computational chemistry and biopharma. President and CEO Ramy Farid, Ph.D., joined in 2002 and has been instrumental in scaling the platform’s commercial reach, while Patrick Lorton serves as Executive Vice President and Chief Technology Officer, overseeing the software’s technical evolution. The leadership team was recently bolstered by the 2025 appointments of Richie Jain as Chief Financial Officer and Mannix Aklian as Chief Commercial Officer. Schrödinger maintains a prestigious investor and governance base, with the Bill & Melinda Gates Foundation Trust and D. E. Shaw affiliates serving as cornerstone shareholders. The Board of Directors, chaired by Michael Lynton, includes prominent industry figures such as former Merck executive Nancy Thornberry and co-founder Richard Friesner.